Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients
暂无分享,去创建一个
M. Yoshiyama | A. Hanatani | A. Doi | K. Sugioka | Yusuke Hayashi | M. Takagi | Jun Kakihara | Shogo Sakamoto
[1] W. Shimizu,et al. Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation , 2016, Heart and Vessels.
[2] V. Hasselblad,et al. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials , 2016, Journal of Interventional Cardiac Electrophysiology.
[3] A. Moss,et al. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis. , 2015, Heart rhythm.
[4] K. Takami,et al. Prophylactic catheter ablation of ventricular tachycardia before cardioverter‐defibrillator implantation in patients with non‐ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation , 2015, Journal of arrhythmia.
[5] D. Babuty,et al. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. , 2014, JACC. Heart failure.
[6] A. Moss,et al. Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) , 2014, Circulation. Arrhythmia and electrophysiology.
[7] A. Moss,et al. Mortality Reduction In Relation To ICD Programming In MADIT-RIT , 2014 .
[8] Angel Arenal,et al. Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population: Data From the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) Trial , 2014, Circulation.
[9] D. Exner,et al. Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.
[10] Y. Nabutovsky,et al. Programming Implantable Cardioverter‐Defibrillators in Patients with Primary Prevention Indication to Prolong Time to First Shock: Results from the PROVIDE Study , 2014, Journal of cardiovascular electrophysiology.
[11] H. Yokoshiki,et al. Suppression of ventricular fibrillation by electrical modification of the Purkinje system in hypertrophic cardiomyopathy , 2014, Heart and Vessels.
[12] A. Moss,et al. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). , 2013, Journal of the American College of Cardiology.
[13] A. Proclemer,et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. , 2013, JAMA.
[14] P. Schauerte,et al. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy , 2013, Heart and Vessels.
[15] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[16] D. Mark,et al. Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.
[17] Wojciech Zareba,et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.
[18] G. Nam,et al. Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[19] E. Fain,et al. Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial , 2005 .
[20] F. Anselme,et al. Incidence and Clinical Relevance of Slow Ventricular Tachycardia in Implantable Cardioverter-Defibrillator Recipients: An International Multicenter Prospective Study , 2005, Circulation.
[21] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[22] Michael O. Sweeney,et al. Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.
[23] B. Wilkoff,et al. Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients , 2004, Journal of cardiovascular electrophysiology.
[24] Wojciech Zareba,et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.
[25] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.